RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/51099
https://w3id.org/ripe/ripe-kg/retraction-notice/51099
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA10E0E50BEC9CF233 |
prov:used |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prism:doi |
10.1155/2023/9849537 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prism:publicationDate |
2023-08-09 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prism:publicationName |
Emergency Medicine International |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
dcterms:publisher |
ripekg:publisher/RIPEP170EADD0429B0D42Hindawi |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
dcterms:title |
A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1155%2F2022%2F4774195 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
owl:Thing |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
owl:sameAs |
https://semopenalex.org/work/W4385694029 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA10E0E50BEC9CF233 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA10E0E50BEC9CF233 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripe:concerns |
ripekg:author/RIPEAU94004D0173EFBA6BQiang Liu |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripe:concerns |
ripekg:work/10.1155%2F2022%2F4774195 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripe:rationale |
Concerns/Issues About Data;Concerns/Issues about Results and/or Conclusions;Concerns/Issues about Referencing/Attributions;Concerns/Issues with Peer Review;Investigation by Journal/Publisher;Investigation by Third Party;Paper Mill;Computer-Aided Content or Computer-Generated Content;Unreliable Results and/or Conclusions |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
ripe:retractionWatchRecordId |
51099 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA10E0E50BEC9CF233-human-1-3 |
ripekg:retraction-notice/51099A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA10E0E50BEC9CF233-inspectai-1-3 |